You are here

viral vectors

Novartis taps Vyriad’s viral vectors to develop in vivo T cell editing

Fierce Biotech

Wed, 11/20/24 - 08:44 pm

Oxford Biomedica stock soars on rosy forecast, talks to buy ABL Europe

Reuters

Wed, 09/20/23 - 08:40 am

Oxford BioMedica

Astellas buys rights to 4D Molecular’s technology in latest gene therapy deal

BioPharma Dive

Mon, 07/10/23 - 09:34 pm

4D Molecular Therapeutics

GeoVax’s Novel Vaccine Platform Induces Both Antibody and T Cell Responses

BioSpace

Fri, 04/8/22 - 10:28 am

Meeting demand: 3 ways to boost viral vector production

Biopharma Reporter

Wed, 08/18/21 - 11:05 am

drug manufacturing